Sol Gel Technologies Ltd (SLGL) Stock Analysis

Sol Gel Technologies Ltd (SLGL) is a publicly traded company in the HEALTHCARE sector. It trades at $73.73, carries a market capitalization of $230.14M. This page summarizes the public market data, fundamentals, and frequently asked questions for SLGL, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Sol Gel Technologies Ltd currently has a Bullish sentiment score of 0.15.

About Sol Gel Technologies Ltd

Sol-Gel Technologies Ltd. is a pioneering clinical-stage pharmaceutical company specializing in the development and commercialization of innovative topical dermatological products. Utilizing its proprietary microencapsulation delivery system, patented in Israel, Sol-Gel aims to enhance the efficacy and safety of treatments for various skin conditions. Headquartered in Ness Ziona, Israel, the company is committed to addressing significant unmet medical needs in dermatology, positioning itself ...

GNG Research Analysis

GNG Research scores Sol Gel Technologies Ltd (SLGL) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for SLGL.

Frequently Asked Questions

Does SLGL pay dividends?

Sol Gel Technologies Ltd (SLGL) does not currently pay a regular dividend.

What is SLGL's market cap?

Sol Gel Technologies Ltd (SLGL) has a market capitalization of $230.14M with a current stock price of $73.73.